GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: MP5D2_CL22A3 | UCB-6114
Compound class:
Antibody
Comment: Ginisortamab (UCB6114) is a human IgG4κ monoclonal antibody that targets the endogenous BMP antagonist peptide gremlin 1. The heavy and light chain peptide sequences of ginisortamab are claimed in UCB Biopharma's patent WO2018115017A2 [1].The patent describes their antibodies as allosteric modulators, whose epitope is distal to the BMP binding site of gremlin 1.
|
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 11604 | ginisortamab |
Synonyms ![]() |
| MP5D2_CL22A3 | UCB-6114 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 1167 |
| Other databases | |
| GtoPdb PubChem SID | 458923804 |
| Search PubMed clinical trials | ginisortamab |
| Search PubMed titles | ginisortamab |
| Search PubMed titles/abstracts | ginisortamab |